Surgical stapler-associated fatalities and adverse events reported to the food and drug administration

被引:45
|
作者
Brown, SL
Woo, EK
机构
[1] US FDA, Ctr Devices & Radiol Hlth, Off Surveillance & Biometr, Div Postmarket Surveillance,Epidemiol Branch, Rockville, MD 20850 USA
[2] US FDA, Ctr Devices & Radiol Hlth, Off Surveillance & Biometr, Div Postmarket Surveillance,Prod Evaluat Branch, Rockville, MD 20850 USA
关键词
D O I
10.1016/j.jamcollsurg.2004.05.264
中图分类号
R61 [外科手术学];
学科分类号
摘要
BACKGROUND: Use of stapling devices has become standard practice in many operations, and these devices have many applications, including ligation and division, resection, anastomosis, and fascial closure. The Food and Drug Administration (FDA) regulates surgical staplers as a medical device. Manufacturers and health-care providers report adverse events occurring during the use of surgical staplers to the FDA. STUDY DESIGN: Two FDA adverse event databases, the Manufacturer and User Facility Device Experience database and the Alternative Summary Reporting database were searched for adverse events related to the use of surgical staplers. An FDA recall database, Oracle System Center Automated Retrieval, was searched for surgical stapler recalls and the reason for these recalls. RESULTS: We characterized adverse events from 112 death, 2,180 injury, and 22,804 malfunction reports from FDA adverse event databases. We described 22 recalls for these products that are listed in an FDA database. A majority of these recalls were related to manufacturing or design problems. CONCLUSIONS: The overall incidence of these events remains unknown; because these products are used so frequently, even uncommon adverse events may affect many patients. It is important for health-care providers to report adverse events to manufacturers so that they may work to improve the design of these devices and reduce use errors that contribute to the events.
引用
收藏
页码:374 / 381
页数:8
相关论文
共 50 条
  • [1] Adverse Events Associated With Botox as Reported in a Food and Drug Administration Database
    Ahsanuddin, Salma
    Roy, Savannah
    Nasser, Wissam
    Povolotskiy, Roman
    Paskhover, Boris
    [J]. AESTHETIC PLASTIC SURGERY, 2021, 45 (03) : 1201 - 1209
  • [2] Adverse Events Associated With Botox as Reported in a Food and Drug Administration Database
    Salma Ahsanuddin
    Savannah Roy
    Wissam Nasser
    Roman Povolotskiy
    Boris Paskhover
    [J]. Aesthetic Plastic Surgery, 2021, 45 : 1201 - 1209
  • [3] Cannabidiol adverse events reported to the Food and Drug Administration
    Menendez, Anelle
    Hinojosa, Maria
    Jaramillo-Stametz, Jeanie
    Forrester, Mathias B.
    [J]. CLINICAL TOXICOLOGY, 2020, 58 (11) : 1177 - 1178
  • [4] Capsaicin adverse events reported to the Food and Drug Administration
    Hogue, Kelly
    Petty, Lizbeth
    Forrester, Mathias B.
    [J]. CLINICAL TOXICOLOGY, 2020, 58 (11) : 1148 - 1149
  • [5] Ivermectin adverse events reported to the food and drug administration
    Avila, Maximillian
    Caceres-Munoz, Alba
    Patel, Arpan
    De la Cruz, Pablo Frias
    Mandair, Satpreet
    Young, Amy
    Forrester, Mathias
    [J]. CLINICAL TOXICOLOGY, 2022, 60 : 63 - 63
  • [6] Adverse Events Associated with Microinvasive Glaucoma Surgery Reported to the Food and Drug Administration
    Duong, Andrew T.
    Yuan, Melissa
    Koenig, Lisa R.
    Rodriguez, Geoffrey H.
    Van Tassel, Sarah H.
    [J]. OPHTHALMOLOGY GLAUCOMA, 2021, 4 (04): : 433 - 435
  • [7] Levothyroxine and liothyronine adverse events reported to the Food and Drug Administration
    Roth, Brett
    Forrester, Mathias B.
    [J]. CLINICAL TOXICOLOGY, 2020, 58 (11) : 1217 - 1217
  • [8] Rabies vaccine adverse events reported to the Food and Drug Administration
    Thomas, Cristina
    Forrester, Mathias B.
    [J]. CLINICAL TOXICOLOGY, 2020, 58 (11) : 1235 - 1235
  • [9] Kratom (mitragynine) adverse events reported to the Food and Drug Administration
    Menendez, Anelle
    Llerena, Orlando
    Forrester, Mathias B.
    [J]. CLINICAL TOXICOLOGY, 2020, 58 (11) : 1177 - 1177
  • [10] Retrospective analysis of dermatologic adverse events associated with hydroxychloroquine reported to the US Food and Drug Administration
    Lipner, Shari R.
    Wang, Yu
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (05) : 1527 - 1529